Enfortumab vedotin

Enfortumab vedotin is an innovative cancer treatment designed to target and destroy specific bladder cancer cells. It is an antibody-drug conjugate, meaning it combines an antibody that recognizes cancer cells with a powerful chemotherapy drug. When administered, the antibody directs the drug precisely to the cancer cells, sparing most healthy tissue. Once attached, the drug enters the cancer cells and releases a toxin that kills them. This targeted approach can improve treatment effectiveness and reduce side effects compared to traditional chemotherapy. Enfortumab vedotin is particularly used for advanced or metastatic bladder cancer that has not responded to other treatments.